Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. [PDF]
Zanetti A, Tomanin R.
europepmc +1 more source
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutation [PDF]
Ahmed, Alia +8 more
core +1 more source
Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants. [PDF]
Zanetti A, D'Avanzo F, Tomanin R.
europepmc +1 more source
Overcoming the barriers to diagnosis of Morquio A syndrome [PDF]
Adeline Tan +20 more
core +1 more source
Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report. [PDF]
Hattori Y +5 more
europepmc +1 more source
Heparan sulfate in cerebrospinal fluid as a biomarker to assess disease severity and for treatment monitoring in patients with Mucopolysaccharidosis Type II: a position statement. [PDF]
Giugliani R +7 more
europepmc +1 more source
Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities. [PDF]
Dempsey J +8 more
europepmc +1 more source
Respiratory insufficiency after brain metastasectomy for extraskeletal Ewing sarcoma in an adult patient with mucopolysaccharidosis type II: a case report. [PDF]
Hoshi M +4 more
europepmc +1 more source
Corneal structure, transparency, thickness and optical density (densitometry), especially as relevant to contact lens wear – a review [PDF]
Doughty, Michael J., Jonuscheit, Sven
core +1 more source
Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc. [PDF]
Manzoli R +7 more
europepmc +1 more source

